Abstract
In continuation of our studies on the genus Salvia fourteen alcoholic extracts of Salvia species were evaluated for their anticholinesterase activity. Among them, the most active extract at 200 μg/mL was found to be S. staminea with the inhibition of 55.17 and 79.75% against enzymes AChE and BChE, respectively. Pure isolated compounds from S. staminea were investigated for anticholinesterase activity at 200 μM, and the abietane diterpenoids ferruginol and taxodione were found to be the most promising isolates, which were then further investigated at five different concentrations, and both diterpenoids exhibited high activity, particularly against BChE enzyme with IC50 values of 7.73 and 10.52 μM, respectively. Salvia chrysophylla and Salvia poculata extracts also exhibited moderate anticholinesterase activity.
Keywords: Anticholinesterase, antioxidant, ferruginol, Salvia species, S. staminea, taxodione
The Natural Products Journal
Title:Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea
Volume: 3 Issue: 1
Author(s): Gulactı Topcu, Ufuk Kolak, Mehmet Ozturk, Mehmet Boga, Seda Damla Hatipoglu, Fatemeh Bahadori, Burcu Culhaoglu and Tuncay Dirmenci
Affiliation:
Keywords: Anticholinesterase, antioxidant, ferruginol, Salvia species, S. staminea, taxodione
Abstract: In continuation of our studies on the genus Salvia fourteen alcoholic extracts of Salvia species were evaluated for their anticholinesterase activity. Among them, the most active extract at 200 μg/mL was found to be S. staminea with the inhibition of 55.17 and 79.75% against enzymes AChE and BChE, respectively. Pure isolated compounds from S. staminea were investigated for anticholinesterase activity at 200 μM, and the abietane diterpenoids ferruginol and taxodione were found to be the most promising isolates, which were then further investigated at five different concentrations, and both diterpenoids exhibited high activity, particularly against BChE enzyme with IC50 values of 7.73 and 10.52 μM, respectively. Salvia chrysophylla and Salvia poculata extracts also exhibited moderate anticholinesterase activity.
Export Options
About this article
Cite this article as:
Topcu Gulactı, Kolak Ufuk, Ozturk Mehmet, Boga Mehmet, Damla Hatipoglu Seda, Bahadori Fatemeh, Culhaoglu Burcu and Dirmenci Tuncay, Investigation of Anticholinesterase Activity of a Series of Salvia Extracts and the Constituents of Salvia staminea, The Natural Products Journal 2013; 3 (1) . https://dx.doi.org/10.2174/2210315511303010003
DOI https://dx.doi.org/10.2174/2210315511303010003 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Current Pharmaceutical Design Inhibition of IκB Phosphorylation by a Novel IKK Inhibitor IMD-1041 Attenuates Myocardial Dysfunction After Infarction
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Epigenetic Regulation Through SIRT1 in Podocytes
Current Hypertension Reviews Kupffer Cell-Dependent Signaling in Thyroid Hormone Calorigenesis: Possible Applications for Liver Preconditioning
Current Signal Transduction Therapy Update to Medicinal Chemistry of Nicotinamide in the Treatment of Ischemia and Reperfusion
Medicinal Chemistry Reviews - Online (Discontinued) Melatonin Could Be Beneficial in SARS-CoV-2 Therapy
The Natural Products Journal Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Leukocyte Function-Associated Antigen-1: Structure, Function and Application Prospects
Protein & Peptide Letters Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Current Pharmaceutical Design Therapeutic Effects of Micronutrient Supplements on Sperm Parameters: Fact or Fiction?
Current Pharmaceutical Design Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry Kinase Inhibitor Conjugates
Current Pharmaceutical Design Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Current Drug Targets Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis
Current Neurovascular Research FTY720: A Most Promising Immunosuppressant Modulating Immune Cell Functions
Mini-Reviews in Medicinal Chemistry Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials
Current Vascular Pharmacology Mechanistic Considerations on the Development of Lung Edema: Vascular, Perivascular and Molecular Aspects from Early Stage to Tissue and Vascular Remodeling Stage
Current Respiratory Medicine Reviews Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension
Current Pharmaceutical Design